(Q43116570)

English

The low dose combination of fenofibrate and rosiglitazone halts the progression of diabetes-induced experimental nephropathy

scientific article published on 27 March 2010

Statements

The low dose combination of fenofibrate and rosiglitazone halts the progression of diabetes-induced experimental nephropathy (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit